Search News
| 98.80 Delayed Data As of Apr 20 |  -1.57 / -1.56%Today’s Change | 67.04 Today|||52-Week Range 104.78 | +16.66% Year-to-Date |
| Can ResMed (RMD) Repeat Stable Device Growth in Q3 Earnings? Apr 19 / Zacks.com - Paid Partner Content |
| Previous close | 100.37 |
| Today’s open | 100.02 |
| Day’s range | 98.22 - 100.08 |
| Volume | 650,535 |
| Average volume (3 months) | 663,770 |
| Market cap | $14.2B |
| Earnings growth (last year) | -3.61% |
| Earnings growth (this year) | +29.27% |
| Earnings growth (next 5 years) | +13.49% |
| Revenue growth (last year) | +12.40% |
| P/E ratio | 49.6 |
| Price/Sales | 5.37 |
| Price/Book | 7.23 |
| Today’s change | Today’s % change | |
|---|---|---|
| VARVarian Medical Syste... | -0.29 | -0.23% |
| LIVNLivaNova PLC | +0.41 | +0.47% |
| NVRONevro Corp | -0.79 | -0.86% |
| IRTCIrhythm Technologies... | -0.69 | -1.11% |
| Next reporting date | April 27, 2018 |
| EPS forecast (this quarter) | $0.81 |
| Annual revenue (last year) | $2.1B |
| Annual profit (last year) | $342.3M |
| Net profit margin | 16.56% |
Sector Health Technology |
Industry Medical Specialties |
Chief Executive Officer & Director Mick Farrell |
President & Chief Operating Officer Rob Douglas |
Corporate headquarters San Diego, California |
